The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection (Q42235540)
Jump to navigation
Jump to search
scientific article published on 5 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection |
scientific article published on 5 March 2014 |
Statements
1 reference
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection (English)
1 reference
Paul M Scola
Li-Qiang Sun
Alan Xiangdong Wang
Jie Chen
Ny Sin
Brian L Venables
Sing-Yuen Sit
Yan Chen
Anthony Cocuzza
Donna M Bilder
Stanley V D'Andrea
Barbara Zheng
Piyasena Hewawasam
Yong Tu
Jacques Friborg
Paul Falk
Dennis Hernandez
Steven Levine
Chaoqun Chen
Fei Yu
Guangzhi Zhai
Diana Barry
Jay O Knipe
Yong-Hae Han
Richard Schartman
Maria Donoso
Kathy Mosure
Michael W Sinz
Tatyana Zvyaga
Andrew C Good
Ramkumar Rajamani
Kevin Kish
Jeffrey Tredup
Herbert E Klei
Qi Gao
Luciano Mueller
Richard J Colonno
Dennis M Grasela
Stephen P Adams
James Loy
Huabin Sun
Hong Shi
Lucy Sun
William Warner
Danshi Li
Jialong Zhu
5 March 2014
1 reference